Ironridge BioPharma to Invest $500,000 in Pressure BioSciences, Inc.

Published: Apr 09, 2012

SOUTH EASTON, Mass., April 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company") today announced that it has entered into a definitive agreement with Ironridge BioPharma Co. ("Ironridge") to purchase $500,000.00 in shares of Series E Convertible Preferred Stock (the "Preferred Stock") of the Company.

Back to news